Anbio Biotechnology NNNN
NASDAQ NNNN
$5.25 -0.35 (-6.25%)
At close: Sep 18, 2026 · 4:00 PM EDT

Anbio Biotechnology (NNNN) Short-term Investments (2023 - 2025)

Anbio Biotechnology (NNNN) posted Short-term Investments of $4.1 million for Q4 2025, down 48.83% on a QoQ basis from $8.1 million in Q2 2025.

Analysis

Anbio Biotechnology (NNNN) Short-term Investments (2023 - 2025) Analysis & Trends

Anbio Biotechnology has reported Short-term Investments for 2 years, with the latest figure at $4.1 million in Q4 2025.

  • On a quarterly basis, Short-term Investments changed N/A year-over-year to $4.1 million in Q4 2025; TTM through Dec 2025 was $4.1 million, a N/A change from a year earlier, with the FY2025 full-year figure at $4.1 million, changed N/A from the prior year.
  • Short-term Investments was $4.1 million for Q4 2025 at Anbio Biotechnology, down from $8.1 million in the prior quarter.
  • The five-year high for Short-term Investments was $8.1 million in Q2 2025, with the low at $3263.0 in Q4 2023.
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 GE HealthCare Technologies 28.97 Bn 27.09 Bn 2.18 Bn
2 Lantheus Holdings 6.56 Bn 5.97 Bn 241.86 Mn
3 Heartflow 4.40 Bn 4.03 Bn 53.19 Mn
4 Neogen 2.83 Bn 2.64 Bn 107.80 Mn
5 Butterfly Network 1.88 Bn 1.75 Bn 23.29 Mn
6 Ceribell 931.50 Mn 802.24 Mn 25.94 Mn
7 Varex Imaging 779.32 Mn 694.02 Mn 76.70 Mn
8 Anbio Biotechnology 755.43 Mn 743.53 Mn -
9 QuidelOrtho 725.35 Mn 601.95 Mn -
10 Prenetics Global 339.92 Mn 280.78 Mn 30.20 Mn
Historic Data

Historic Data

Download Data
DateValue
Dec 31, 2025 4.13 Mn
Jun 30, 2025 8.08 Mn
Dec 31, 2023 3,263.00